NEW DELHI: India has achieved a big breakthrough with the creation of Nafithromycin, a new antibiotic marketed as Miqnaf, to handle severe cases of sepsis, bacterial and viral infections. This new antibiotic, targets Community-Acquired Bacterial Pneumonia (CABP), a condition that causes over 2 million fatalities globally each year and will help in fight against antimicrobial resistance […]
NEW DELHI: Torrent Pharmaceuticals has strongly denied claims that a batch of its widely used Shelcal 500 failed a quality test conducted by the Central Drugs Standard Control Organization (CDSCO). The company clarified that the sample in question, seized by CDSCO, was not manufactured by Torrent and was identified as counterfeit. Recent media reports cited […]
iNCOVACC will be the world’s first COVID-19 booster dose. It will give India more options to choose from when it comes to third doses or precautionary doses
Bharat Biotech’s Intranasal Vaccine receives both Primary series and Heterologous booster approval from from the Central Drugs Standard Control Organisation (CDSCO). This is first ever Intranasal Vaccine approved under restricted emergency use for 18+ for heterologous booster doses.. This vaccine was tested on 3100 candidates at 14 trial sites across India majorly for immunogenicity during […]
A day after the Subject Expert Committee (SEC) meeting discussed the Kiran Majumdar Shaw-led Biocon Biologics Limited (BBL)’s Insulin Aspart injection, an executive of her company asked middlewoman Guljit Sethi to modify the recommendations of the committee, the Central Bureau of Investigation (CBI) said. Agency sources told The New Indian that while investigating the alleged bribery case, […]
NEW DELHI: A local court on Friday reserved its order on the bail application of four accused in the Rs 4 lakhs bribery scandal involving pharma major Biocon Biologics and Drugs Controller General of India (DCGI) officials arrested last month. The special CBI court will pronounce its judgment on the bail pleas of Joint […]